7,750 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Zweig DiMenna Associates LLC

Zweig DiMenna Associates LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 7,750 shares of the biotechnology company’s stock, valued at approximately $4,606,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Public Sector Pension Investment Board lifted its holdings in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after acquiring an additional 500 shares during the period. CIBC Asset Management Inc increased its position in shares of Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the last quarter. Foundations Investment Advisors LLC bought a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $221,000. Sequoia Financial Advisors LLC boosted its holdings in shares of Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after buying an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC bought a new stake in Axon Enterprise during the third quarter valued at approximately $814,000. 79.08% of the stock is owned by institutional investors.

Insider Activity at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 50,545 shares of company stock valued at $30,721,337. Insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of several recent research reports. JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. The Goldman Sachs Group raised their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $504.92.

Axon Enterprise Trading Down 0.3 %

Shares of Axon Enterprise stock opened at $611.43 on Friday. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a 50-day moving average price of $617.43 and a 200-day moving average price of $467.42. The firm has a market cap of $46.62 billion, a price-to-earnings ratio of 157.99, a PEG ratio of 6.09 and a beta of 1.04.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.